Pharmaceutical Technology
FEBRUARY 3, 2023
Only a few weeks into the new year, the prospect of getting a successful advanced HIV vaccine shrank after the discontinuation of yet another late-stage trial. On January 18, Janssen, a Johnson & Johnson (J&J) subsidiary, stated that its vaccine was not effective in preventing HIV infections.
pharmaphorum
SEPTEMBER 22, 2022
Alexandre Le Vert, CEO and co-founder of Osivax, discusses the company’s breakthrough vaccine technology, oligoDOM, and how it’s driving the development of new influenza and SARS-CoV-2 vaccines that attack T-cells, providing a long-lasting effect. The technology. Antibodies cover the pathogen of the virus and neutralise it.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
PharmaShots
APRIL 13, 2023
Through the inclusion of Pharmacia’s products along with a strong performance, Pfizer’s pharmaceutical and animal health revenue was boosted by 40% and 43% respectively In the year 2003, Johnson & Johnson generated a revenue of $41.9B which depicted a growth of 15.3% as compared to the previous year. from last year.
STAT
JULY 5, 2023
agency and Colombian authorities of problems at the Caucaseco Scientific Research Center and Malaria Vaccine Development Center. Both are run by a husband-and-wife team that has received more than $17 million in NIH funding since 2003, according to the animal rights group.
Pharmaceutical Technology
JULY 23, 2008
” “Between 2003 and 2005 global sales for cancer-treating drugs grew by 40%.” “You can get vaccines now to prevent cervical cancer. “And there’s a tremendous opportunity to meet their needs.” “For certain cancers, yes,” says Ando.
ISPE
OCTOBER 26, 2022
ATMP facilities are different from conventional pharmaceutical facilities that process other traditional modalities, such as vaccines and monoclonal antibodies (mAbs), and often require heightened segregation and smaller footprints. Viral antigen vaccines. For example: Live vaccine manufacturing. Complete Data Gathering.
STAT
JULY 6, 2023
agency and Colombian authorities of problems at the Caucaseco Scientific Research Center and the Malaria Vaccine Development Center. Both are run by a husband-and-wife team that has received more than $17 million in NIH funding since 2003, according to the animal rights group.
Expert insights. Personalized for you.
117 
Let's personalize your content